Literature DB >> 22811354

Prolidase and oxidative stress in chronic hepatitis C.

Fazilet Duygu1, Suda Tekin Koruk, Hasan Karsen, Nurten Aksoy, Abdullah Taskin, Melek Hamidanoglu.   

Abstract

BACKGROUND: Hepatitis C infection represents a common healthcare issue worldwide. The present trial was designed to investigate the role of prolidase, an enzyme that is significantly involved in the biosynthesis of collagen, and of the oxidative stress that is considered to be involved in the pathogenesis of various diseases, in the chronic hepatitis C infection. The trial was performed to assess the serum prolidase enzyme level and the oxidative-antioxidative status and to determine the relation between the serum prolidase activity and the oxidative stress parameters.
METHODS: A total of 95 individuals, including 55 patients with chronic hepatitis C infection (CHC) and 40 healthy adults, were enrolled in the trial. The values for prolidase, the total antioxidant status (TAS), the total oxidative stress (TOS), the oxidative stress index (OSI), sulfhydryl (SH), lipid peroxidation LOOH, catalase (CAT), and ceruloplasmin were measured and compared between the patient groups.
RESULTS: The prolidase, TOS, LOOH, CAT, and the OSI values were higher in the chronic hepatitis C group compared to the control group (P < 0.001). The TAS, SH, and ceruloplasmin levels were lower in the CHC group relative to the control group (P < 0.001).
CONCLUSION: We suppose that the values of prolidase and the oxidative stress are increased while the antioxidant levels are decreased in CHC. As a result, prolidase and the oxidative stress seem to be related with the progression of the disease.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22811354      PMCID: PMC6807348          DOI: 10.1002/jcla.21510

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

2.  A simple method for determination of serum catalase activity and revision of reference range.

Authors:  L Góth
Journal:  Clin Chim Acta       Date:  1991-02-15       Impact factor: 3.786

Review 3.  Prolidase deficiency and the biochemical assays used in its diagnosis.

Authors:  Biji T Kurien; Nisha C Patel; Andrew C Porter; Anil D'Souza; Dave Miller; Hiroyuki Matsumoto; Heng Wang; R Hal Scofield
Journal:  Anal Biochem       Date:  2005-10-27       Impact factor: 3.365

4.  Serum prolidase enzyme activity and its relation to histopathological findings in patients with non-alcoholic steatohepatitis.

Authors:  Mehmet Horoz; Mehmet Aslan; Fusun F Bolukbas; Cengiz Bolukbas; Yasar Nazligul; Hakim Celik; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 5.  Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

Authors:  B Halliwell
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

6.  Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Hiroshi Sakugawa; Tomofumi Nakayoshi; Kasen Kobashigawa; Tsuyoshi Yamashiro; Tatsuji Maeshiro; Satoru Miyagi; Joji Shiroma; Akiyo Toyama; Tomokuni Nakayoshi; Fukunori Kinjo; Atsushi Saito
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

7.  Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis.

Authors:  K Moriya; K Nakagawa; T Santa; Y Shintani; H Fujie; H Miyoshi; T Tsutsumi; T Miyazawa; K Ishibashi; T Horie; K Imai; T Todoroki; S Kimura; K Koike
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

8.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

9.  A novel automated method to measure total antioxidant response against potent free radical reactions.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2004-02       Impact factor: 3.281

10.  Plasma prolidase and prolinase activity in alcoholic liver disease.

Authors:  B Brosset; I Myara; M Fabre; A Lemonnier
Journal:  Clin Chim Acta       Date:  1988-07-29       Impact factor: 3.786

View more
  11 in total

1.  The relationships among the levels of oxidative and antioxidative parameters, FEV1 and prolidase activity in COPD.

Authors:  Selami Ekin; Ahmet Arısoy; Hulya Gunbatar; Bunyamin Sertogullarindan; Aysel Sunnetcioglu; Hatice Sezen; Selvi Asker; Hanifi Yıldız
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

2.  Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.

Authors:  Sevil Uygun Ilikhan; Muammer Bilici; Hatice Sahin; Ayşe Semra Demir Akca; Murat Can; Ibrahim Ilker Oz; Berrak Guven; M Cagatay Buyukuysal; Yucel Ustundag
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 3.  Role of oxidative stress in infectious diseases. A review.

Authors:  Miroslav Pohanka
Journal:  Folia Microbiol (Praha)       Date:  2013-03-17       Impact factor: 2.099

4.  Does prolidase indicate worsening of hepatitis B infection?

Authors:  Fazilet Duygu; Nurten Aksoy; Aysegul Copur Cicek; Ilknur Butun; Sebnem Unlu
Journal:  J Clin Lab Anal       Date:  2013-09       Impact factor: 2.352

5.  Oxidative stress response in patients infected by diverse hepatitis C virus genotypes.

Authors:  Mohammad Hassan Khadem Ansari; Mir-Davood Omrani; Fatemeh Kheradmand
Journal:  Hepat Mon       Date:  2015-02-21       Impact factor: 0.660

6.  Serum prolidase activity and oxidant-antioxidant status in children with chronic hepatitis B virus infection.

Authors:  Velat Şen; Ünal Uluca; Aydın Ece; İbrahim Kaplan; Fatma Bozkurt; Fesih Aktar; Sedat Bağlı; Recep Tekin
Journal:  Ital J Pediatr       Date:  2014-11-26       Impact factor: 2.638

7.  Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer.

Authors:  Faruk Kucukdurmaz; Erkan Efe; Ahmet Çelik; Hasan Dagli; Metin Kılınc; Sefa Resim
Journal:  BMC Urol       Date:  2017-12-12       Impact factor: 2.264

8.  Enhanced Efficacy of Direct-Acting Antivirals in Hepatitis C Patients by Coadministration of Black Cumin and Ascorbate as Antioxidant Adjuvants.

Authors:  Sarfraz Ahmed; Adeela Zahoor; Muhammad Ibrahim; Muhammad Younus; Sadia Nawaz; Rahat Naseer; Qaiser Akram; Cun-Liang Deng; Suvash Chandra Ojha
Journal:  Oxid Med Cell Longev       Date:  2020-06-03       Impact factor: 6.543

9.  Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial.

Authors:  Sarfraz Ahmed; Najeeb Ullah; Sadia Parveen; Ifra Javed; Nur Asyilla Che Jalil; Mogana Das Murtey; Irfan Shahzad Sheikh; Shahroz Khan; Suvash Chandra Ojha; Ke Chen
Journal:  Oxid Med Cell Longev       Date:  2022-02-02       Impact factor: 6.543

Review 10.  Mitochondrial dysfunctions and altered metals homeostasis: new weapons to counteract HCV-related oxidative stress.

Authors:  Mario Arciello; Manuele Gori; Clara Balsano
Journal:  Oxid Med Cell Longev       Date:  2013-11-24       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.